USP17L2
Ubiquitin carboxyl-terminal hydrolase 17
Also known as: DUB3, U17L2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6R6M4
- Gene
- USP17L2
- Ensembl
- ENSG00000223443
- Chromosome
- 8
- Canonical length
- 530 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
Enables cysteine-type deubiquitinase activity. Involved in several processes, including CAAX-box protein processing; protein deubiquitination; and regulation of defense response. Located in endoplasmic reticulum membrane and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
530 residues, UniProt reviewed canonical sequence.
>Q6R6M4|USP17L2
1 MEDDSLYLGG EWQFNHFSKL TSSRPDAAFA EIQRTSLPEK SPLSSEARVD LCDDLAPVAR
61 QLAPRKKLPL SSRRPAAVGA GLQNMGNTCY ENASLQCLTY TPPLANYMLS REHSQTCQRP
121 KCCMLCTMQA HITWALHSPG HVIQPSQALA AGFHRGKQED AHEFLMFTVD AMKKACLPGH
181 KQVDHHSKDT TLIHQIFGGC WRSQIKCLHC HGISDTFDPY LDIALDIQAA QSVKQALEQL
241 VKPEELNGEN AYHCGLCLQR APASKTLTLH TSAKVLILVL KRFSDVTGNK LAKNVQYPEC
301 LDMQPYMSQQ NTGPLVYVLY AVLVHAGWSC HDGHYFSYVK AQEGQWYKMD DAKVTACSIT
361 SVLSQQAYVL FYIQKSEWER HSESVSRGRE PRALGAEDTD RRATQGELKR DHPCLQAPEL
421 DERLVERATQ ESTLDHWKFP QEQNKTKPEF NVRKVEGTLP PNVLVIHQSK YKCGMKNHHP
481 EQQSSLLNLS STTRTDQESV NTGTLASLQG RTRRSKGKNK HSKRALLVCQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against USP17L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- skin: 0.2 nTPM
- ovary: 0.1 nTPM
- retina: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- cardiomyocytes: 0.1 nCPM
- gonadotrophs: 0.1 nCPM
- lactotrophs: 0.1 nCPM
- renal collecting duct principal cells: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 63 nTPM
- cerebral cortex: 61 nTPM
- hypothalamus: 58 nTPM
- basal ganglia: 55 nTPM
- white matter: 55 nTPM
- amygdala: 50 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -5.84
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- CAAX-box protein processing
- MAPK cascade
- negative regulation of GTPase activity
- negative regulation of protein processing
- negative regulation of protein targeting to membrane
- positive regulation of GTPase activity
- positive regulation of MDA-5 signaling pathway
- positive regulation of RIG-I signaling pathway
- protein deubiquitination
- protein K48-linked deubiquitination
- protein K63-linked deubiquitination
- regulation of apoptotic process
- regulation of cell migration
- regulation of cell population proliferation
- regulation of defense response to virus by host
- regulation of protein stability
- regulation of ruffle assembly
- regulation of G2/MI transition of meiotic cell cycle
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of USP17L2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads USP17L2 as an antibody target. Whether an autoantibody or antibody against USP17L2 could matter depends on whether native USP17L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
USP17L2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label USP17L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...